Andere Kunden interessierten sich auch für
![Molecular and Clinical Impact of BCR-ABL Fusion Transcripts in CML]( "Molecular and Clinical Impact of BCR-ABL Fusion Transcripts in CML")
Molecular and Clinical Impact of BCR-ABL Fusion Transcripts in CML51,99 €![Development of a quantification method for European brown hares (Lepus europaeus) in urban areas on the example of Lichtenberg, Berlin]( "Development of a quantification method for European brown hares (Lepus europaeus) in urban areas on the example of Lichtenberg, Berlin")
Development of a quantification method for European brown hares (Lepus europaeus) in urban areas on the example of Lichtenberg, Berlin47,95 €![Rett Syndrome mutations: molecular alterations at neuronal synapses]( "Rett Syndrome mutations: molecular alterations at neuronal synapses")
Rett Syndrome mutations: molecular alterations at neuronal synapses32,99 €![Detection Molecular of E.coli O157:H7 Bacteria From Raw Cows Milk]( "Detection Molecular of E.coli O157:H7 Bacteria From Raw Cows Milk")
Detection Molecular of E.coli O157:H7 Bacteria From Raw Cows Milk40,99 €![Molecular Detection of Genetically Modified Tomatoes in Iraqi market]( "Molecular Detection of Genetically Modified Tomatoes in Iraqi market")
Molecular Detection of Genetically Modified Tomatoes in Iraqi market29,99 €![Molecular Studies on Gene Types Resistant to Potato Virus Y]( "Molecular Studies on Gene Types Resistant to Potato Virus Y")
Molecular Studies on Gene Types Resistant to Potato Virus Y40,99 €![Detection of some AML Fusion Genes by Molecular Biology Technique]( "Detection of some AML Fusion Genes by Molecular Biology Technique")
Detection of some AML Fusion Genes by Molecular Biology Technique32,99 €
This study was designed as a try to apply molecular, conventional cytogenetic, and immunological techniques as conformational diagnosis of bcr-abl gene and protein, and also to follow up chronic myeloid leukemia patients (CML) treated with imatinb mesylate (IM) for assessment of response at different IM treatment durations. Molecular screening for the presence of bcr-abl gene in 34 CML patients and negative controls were done using Multiplex-Single Step-Reverse Transcriptase-Polymerase Chain Reaction. The results showed that all CML patients were positive for bcr-abl gene while all the others were negative for this gene. For assessment of molecular response to IM, quantification of bcr-abl gene in CML patients were done using Real Time-Reverse Transcriptase-Polymerase Chain Reaction-Taqman.CML patients, who show signs of treatment non-response or relapse, were screened for T315I mutation using Allele Specific oligonucleotides. The results showed that this mutation dose not detected in any of those patients.In conclusion, obligatory complementary tests that should be performed for any CML patient who start to receive IM, in order to assess the full respons to therapy.